Toluene exposure during the brain growth spurt reduces behavioral responses to noncompetitive N-methyl-D-aspartate receptor antagonists in adult rats

Psychopharmacology

Volumn 182, Issue 4, 2005, Pages 468-474

  Chien, Te Hsiung ^a,b   Chan, Ming Huan ^a   Tang, Yu Chi ^a   Chen, Hwei Hsien ^a  

^a TZU CHI UNIVERSITY   (Taiwan)

^b CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

Author keywords

Fetal solvent syndrome; Ketamine; MK 801; Toluene

Indexed keywords

DIZOCILPINE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; SOLVENT; TOLUENE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BRAIN DEVELOPMENT; BRAIN GROWTH; COGNITION; COGNITIVE DEFECT; COMPUTER SYSTEM; CONTROLLED STUDY; HYPNOSIS; LOCOMOTION; LONG TERM MEMORY; MALE; MOTOR COORDINATION; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; RIGHTING REFLEX; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BRAIN; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; KETAMINE; MALE; MOTOR ACTIVITY; PREGNANCY; PSYCHOMOTOR PERFORMANCE; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; REFLEX; TIME FACTORS; TOLUENE;

EID: 26844448668     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0137-x     Document Type: Article

References (31)

1. Adams B, Moghaddam B (1998) Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18:5545-5554
2. Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci 13:272-276
3. Carlsson ML, Martin P, Nilsson M, Sorensen SM, Carlsson A, Waters S, Waters N (1999) The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist-than dopamine agonist-induced hyperactivity in mice. J Neural Transm 106:123-129
4. Chen HH, Lee YF (2002) Neonatal toluene exposure selectively alters sensitivity to different chemoconvulsant drugs in juvenile rats. Pharmacol Biochem Behav 73:921-927
5. Corbett R, Camacho F, Woods AT, Kerman LL, Fishkin RJ, Brooks K, Dunn RW (1995) Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology 120:67-74
6. Cruz SL, Mirshahi T, Thomas B, Balster RL, Woodward JJ (1998) Effects of the abused solvent toluene on recombinant N-methyl-D-aspartate and non-N-methyl-D-aspartate receptors expressed in Xenopus oocytes. J Pharmacol Exp Ther 286:334-340
7. Cull-Candy S, Brickley S, Farrant M (2001) NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 11:327-335
8. Dall'Igna OP, Da Silva AL, Dietrich MO, Hoffmann A, de Oliveira RV, Souza DO, Lara DR (2003) Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice. Psychopharmacology 166:258-263
9. Dobbing J, Sands J (1979) Comparative aspects of the brain growth spurt. Early Hum Dev 3:79-83
10. D'Souza DN, Harlan RE, Garcia MM (2002) Sexually dimorphic effects of morphine and MK-801: sex steroid-dependent and -independent mechanisms. J Appl Physiol 92:493-503
11. Garriott JC, Foerster E, Juarez L, de la Garza F, Mendiola I, Curoe J (1981) Measurement of toluene in blood and breath in cases of solvent abuse. Clin Toxicol 18:471-479
12. Gureviciene I, Puolivali J, Pussinen R, Wang J, Tanila H, Ylinen A (2003) Estrogen treatment alleviates NMDA-antagonist induced hippocampal LTP blockade and cognitive deficits in ovariectomized mice. Neurobiol Learn Mem 79:72-80
13. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K, Tenkova TI, Stefovska V, Turski L, Olney JW (1999) Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283:70-74
14. Ikonomidou C, Bittigau P, Ishimaru MJ, Wozniak DF, Koch C, Genz K, Price MT, Stefovska V, Horster F, Tenkova T, Dikranian K, Olney JW (2000) Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 287:1056-1060
15. Ishii T, Moriyoshi K, Sugihara H, Sakurada K, Kadotani H, Yokoi M, Akazawa C, Shigemoto R, Mizuno N, Masu M et al (1993) Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J Biol Chem 268:2836-2843
16. Kelland MD, Soltis RP, Boldry RC, Walters JR (1993) Behavioral and electrophysiological comparison of ketamine with dizocilpine in the rat. Physiol Behav 54:547-554
17. Laurie DJ, Seeburg PH (1994) Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition. Eur J Pharmacol 268:335-345
18. Lee YF, Lo PS, Wang YJ, Hu A, Chen HH (2005) Neonatal toluene exposure alters N-methyl-D-aspartate receptor subunit expression in the hippocampus and cerebellum in juvenile rats. Neuropharmacology 48:195-203
19. Lennartz RC, Gold PE (1995) Glucose does not reverse impairments on spontaneous alternation induced by the noncompetitive NMDA antagonist MK-801. Neurobiol Learn Mem 63:107-110
20. Mirjana C, Baviera M, Invernizzi RW, Balducci C (2004) The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex. Neuropsychopharmacology 29:1637-1647
21. Moghaddam B, Adams B, Verma A, Daly D (1997) Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 17:2921-2927
22. Monaghan DT, Larsen H (1997) NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology. J Pharmacol Exp Ther 280:614-620
23. Park SW, Kim N, Yang Y, Seo B, Paeng KJ (1998) Toluene distribution of glue sniffers' biological fluid samples in Korea. J Forensic Sci 43:888-890
24. Pearson MA, Hoyme HE, Seaver LH, Rimsza ME (1994) Toluene embryopathy: delineation of the phenotype and comparison with fetal alcohol syndrome. Pediatrics 93:211-215
25. Rodriguez-Paz JM, Anantharam V, Treistman SN (1995) Block of the N-methyl-D-aspartate receptor by phencyclidine-like drugs is influenced by alternative splicing. Neurosci Lett 190:147-150
26. Scheetz AJ, Constantine-Paton M (1994) Modulation of NMDA receptor function: implications for vertebrate neural development. FASEB J 8:745-752
27. Shumilina AV (1991) The experimental transplacental passage of dimethylformamide and toluene. Akush Ginekol 11:49-51
28. Spear LP (2000) The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24:417-463
29. Takahata R, Moghaddam B (2003) Activation of glutamate neurotransmission in the prefrontal cortex sustains the motoric and dopaminergic effects of phencyclidine. Neuropsychopharmacology 28:1117-1124
30. Verma A, Kulkarni SK (1992) Modulation of MK-801 response by dopaminergic agents in mice. Psychopharmacology 107:431-436
31. Zanatta MS, Schaeffer E, Schmitz PK, Medina JH, Quevedo J, Quillfeldt JA, Izquierdo I (1996) Sequential involvement of NMDA receptor-dependent processes in hippocampus, amygdala, entorhinal cortex and parietal cortex in memory processing. Behav Pharmacol 7:341-345